Beyond Diuretics: Management of Volume Overload in Acute Heart Failure Syndromes

James A. Hill*, Clyde W. Yancy, William T. Abraham

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Diuretics are an established foundation of therapy for patients with chronic heart failure (HF) as well as for those hospitalized for treatment of acute HF syndromes. Despite the accepted use of diuretics in acute HF syndromes, treatment patterns with diuretics vary widely, and there are no data from randomized studies on the benefit of diuretics on morbidity or mortality in patients hospitalized with acute HF syndromes. Additional pharmacologic therapies that complement or replace diuretics in this setting, especially in patients with diuretic resistance, include positive inotropes, nitrovasodilators, and natriuretic peptides, but data are likewise lacking on important clinical outcomes. Ultrafiltration has also been used as a nonpharmacologic strategy to treat patients with acute HF syndromes who exhibit resistance to diuretics. Effective monitoring of volume status with newer modalities may allow more selective use of diuretics and diuretic-like modalities, but additional randomized trial data are clearly needed to establish ideal strategies to promote volume removal in acute HF syndromes.

Original languageEnglish (US)
Pages (from-to)S37-S44
JournalAmerican Journal of Medicine
Issue number12 SUPPL.
StatePublished - Dec 2006


  • Diuretics
  • Heart failure
  • Inotropes
  • Treatment
  • Vasodilators

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Beyond Diuretics: Management of Volume Overload in Acute Heart Failure Syndromes'. Together they form a unique fingerprint.

Cite this